257 related articles for article (PubMed ID: 1934682)
1. High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community.
Noltorp S; Svensson B
Clin Exp Rheumatol; 1991; 9(4):351-5. PubMed ID: 1934682
[TBL] [Abstract][Full Text] [Related]
2. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988.
Franzén P; Sutinen S; von Knorring J
J Rheumatol; 1992 Feb; 19(2):273-6. PubMed ID: 1629827
[TBL] [Abstract][Full Text] [Related]
3. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
Crowson CS; Matteson EL
Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
[TBL] [Abstract][Full Text] [Related]
4. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N
Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168
[TBL] [Abstract][Full Text] [Related]
5. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94.
Gran JT; Myklebust G
J Rheumatol; 1997 Sep; 24(9):1739-43. PubMed ID: 9292797
[TBL] [Abstract][Full Text] [Related]
6. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
Lally L; Spiera R
Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
[TBL] [Abstract][Full Text] [Related]
7. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
Pujades-Rodriguez M; Duyx B; Thomas SL; Stogiannis D; Smeeth L; Hemingway H
Heart; 2016 Mar; 102(5):383-9. PubMed ID: 26786818
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden.
Ji J; Liu X; Sundquist K; Sundquist J; Hemminki K
Rheumatology (Oxford); 2010 Jun; 49(6):1158-63. PubMed ID: 20299378
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy.
Salvarani C; Macchioni P; Zizzi F; Mantovani W; Rossi F; Castri C; Capozzoli N; Baricchi R; Boiardi L; Chiaravalloti F
Arthritis Rheum; 1991 Mar; 34(3):351-6. PubMed ID: 2003856
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.
Bengtsson BA; Malmvall BE
Arthritis Rheum; 1981 Jul; 24(7):899-904. PubMed ID: 7259802
[TBL] [Abstract][Full Text] [Related]
11. Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden.
Ji J; Dimitrijevic I; Sundquist J; Sundquist K; Zöller B
Scand J Rheumatol; 2017 Nov; 46(6):484-489. PubMed ID: 28276953
[TBL] [Abstract][Full Text] [Related]
12. [Synchronous variations in the incidence of temporal arteritis and polymyalgia rheumatica in Danish counties. Association with epidemics of Mycoplasma pneumonia infection].
Elling P; Olsson AT; Elling H
Ugeskr Laeger; 1997 Jun; 159(26):4123-8. PubMed ID: 9229871
[TBL] [Abstract][Full Text] [Related]
13. Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritis.
Kyle V; Wraight EP; Hazleman BL
Clin Rheumatol; 1991 Sep; 10(3):294-7. PubMed ID: 1790639
[TBL] [Abstract][Full Text] [Related]
14. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
15. Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis.
Narváez J; Nolla-Solé JM; Clavaguera MT; Valverde-García J; Roig-Escofet D
J Rheumatol; 1999 Sep; 26(9):1945-52. PubMed ID: 10493675
[TBL] [Abstract][Full Text] [Related]
16. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection.
Elling P; Olsson AT; Elling H
J Rheumatol; 1996 Jan; 23(1):112-9. PubMed ID: 8838518
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study.
Kobayashi D; Suyama Y; Osugi Y; Arioka H; Takahashi O; Kuriyama N
Int J Rheum Dis; 2018 Jun; 21(6):1314-1321. PubMed ID: 29879315
[TBL] [Abstract][Full Text] [Related]
18. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of polymyalgia rheumatica and giant cell arteritis.
Salvarani C; Pipitone N; Versari A; Hunder GG
Nat Rev Rheumatol; 2012 Sep; 8(9):509-21. PubMed ID: 22825731
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids.
Andersson R; Malmvall BE; Bengtsson BA
Acta Med Scand; 1986; 220(4):361-4. PubMed ID: 3799241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
